首页 正文

Clinical Development and Therapeutic Applications of Bispecific Antibodies for Hematologic Malignancies

{{output}}
Bispecific antibodies are composed of two monoclonal antibodies that engage T cells with tumor cell antigens and lead to tumor cell lysis. The most common types fall into the category of bispecific T cell engagers, or BiTEs, that have the canonical CD3-CD19 bi... ...